Sort
21,453 grants matching “tuberculosis”
CD8 Tau cell contraction and memory formation
$245,930Martin Prlic · Fred Hutchinson Cancer Research Center · R00 · FY2012 · AI
Viral Testing Core
$245,874Koen K Van Rompay · University Of California At Davis · U42 · FY2020 · OD
Study of responses to CD44 targeted nanovectors to design a novel adjunctive anti-tuberculosis host-directed therapy
$245,811Soumya Chatterjee · Saint Louis University · R21 · FY2019 · AI
Resistance-gene-guided genome mining for novel antifungal compounds
$245,768Berl Ray Oakley · University Of Kansas Lawrence · R21 · FY2021 · AI
Roles of Rv0805 in biology of M. tuberculosis
$245,651Kathleen A. McDonough · Wadsworth Center · R21 · FY2018 · AI
Cryptococcal Exploitation of the Blood-Brain Barrier
$245,625Kwang S Kim · Johns Hopkins University · R21 · FY2020 · AI
DEVELOP GENOMEWIDE TECHNOLOGY TO PROFILE DNA ADP-RIBOSYLATION
$245,625Anthony K L Leung · Johns Hopkins University · R21 · FY2025 · GM
PpiA, a multitasking mycobacterial virulence protein
$245,625William Ramses Bishai · Johns Hopkins University · R21 · FY2019 · AI
Cell death pathway leading to vacuole permeabilization
$245,625J. Marie Hardwick · Johns Hopkins University · R21 · FY2024 · AI
A strategy to treat M. abscessus infections
$245,625Gyanu Lamichhane · Johns Hopkins University · R21 · FY2020 · AI
Oral dual β-lactams to treat pulmonary M. abscessus disease
$245,625Gyanu Lamichhane · Johns Hopkins University · R21 · FY2021 · AI
Pro-Apoptotic BCG as an HCV vaccine vector
$245,625Spyros A Kalams · Vanderbilt University · R21 · FY2009 · AI
Measuring Intralesional Bedaquiline Exposures in Cavitary TB Using Noninvasive In Vivo PET Imaging
$245,625Sanjay Jain · Johns Hopkins University · R21 · FY2020 · AI
BEYOND BURDEN: NEW TOOLS FOR TUBERCULOSIS ANTIBIOTICREGIMEN DESIGN
$245,619Martin Inua Voskuil · University Of Colorado Denver · R21 · FY2024 · AI
International Core
$245,613Robert Gross · University Of Pennsylvania · P30 · FY2024 · AI
TB goes viral: Interplay between mycobacteria RNA and host cytosolic surveillance pathways
$245,594William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI
How do lysosomal disorders drive susceptibility to M.tb?
$245,594William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI
Immunotherapy Targeting MTB Persisters in the DC-impaired Setting of HIV and TB
$245,563Petros C Karakousis · Johns Hopkins University · R21 · FY2018 · AI
Regulation of allergen-induced mast cell activation and allergic inflammation through DCIR
$245,563Peisong Gao · Johns Hopkins University · R21 · FY2018 · AI
Evaluation of PARP-1 as a target of host-directed therapy in tuberculosis
$245,563William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI
Unraveling the link between serine/threonine protein kinase and two-component system regulation of environment-mediated Mycobacterium tuberculosis growth arrest
$245,550Shumin Tan · Tufts University Boston · R21 · FY2022 · AI
Exploiting a robust drug discovery portfolio to develop effective regimens to treat Mycobacterium abscessus lung infection
$245,438Eric L Nuermberger · Johns Hopkins University · R21 · FY2018 · AI
Targeting host immune cells and DAMP molecules to improve outcome in tuberculosis
$245,438William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI
Investigations of the Bioinorganic Chemistry of Iron: New Siderophores
$245,386Alison Butler · University Of California Santa Barbara · R01 · FY2009 · GM
Mycobacterium turberculosis metal transport P-type ATPases
$245,382Jose M Arguello · Worcester Polytechnic Institute · R21 · FY2009 · AI